Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients.

Türk, Murat; Bahçecioglu, Sakine Nazik; Tutar, Nuri; Oymak, Fatma Sema; Gülmez, Inci; Yilmaz, Insu

Türk, Murat; Bahçecioglu, Sakine Nazik; Tutar, Nuri; Oymak, Fatma Sema; Gülmez, Inci; Yilmaz, Insu.

Afiliación

Türk M; Division of Allergy and Clinical Immunology, Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Turkey.
Bahçecioglu SN; Division of Allergy and Clinical Immunology, Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Turkey.
Tutar N; Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Turkey.
Oymak FS; Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Turkey.
Gülmez I; Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Turkey.
Yilmaz I; Division of Allergy and Clinical Immunology, Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Turkey.

Turk Thorac J ; 19(4): 187-192, 2018 10.

Article en En | MEDLINE | ID: mdl-30322442

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Turk Thorac J Año: 2018 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google